Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate-Reference-Cited by-同舟云学术

Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate

Published:2020-08 Issue: Volume:97 Page:365-370
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Cressey Tim R.^ORCID,Siriprakaisil Oraphan,Kubiak Rachel W.^ORCID,Klinbuayaem Virat,Sukrakanchana Pra-ornsuda,Quame-Amaglo Justice^ORCID,Okochi Hideaki,Tawon Yardpiroon,Cressey Ratchada,Baeten Jared M.,Gandhi Monica,Drain Paul K.

Funder

ational Institute of Allergy and Infectious Diseases, N

ational Institutes of Health

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference32 articles.

1. Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection;Anderson;J Antimicrob Chemother,2011

2. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men;Anderson;Sci Transl Med,2012

3. TFV-DP in dried blood spots (DBS) following directly observed therapy: dot-DBS study;Anderson,2017

4. TRUVADA® (emtricitabine/tenofovir disoproxil fumarate) Tablets, for Oral Use. Package Insert,2004

5. WHO Technical Update on Pre-Exposure Prophylaxis (PrEP),2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Point-of-care urine tenofovir monitoring of adherence to drive interventions for HIV treatment and prevention;Expert Review of Molecular Diagnostics;2024-02-14

2. Ex vivo rectal tissue infection with HIV-1 to assess time to protection following oral PrEP with TDF/FTC (a sub-study of the ANRS PREVENIR study);AIDS;2023-11-16

3. The Hepatoprotective Effects of Moringa oleifera against Antiretroviral-Induced Cytotoxicity in HepG2 Cells: A Review;Plants;2023-09-12

4. Inflammatory properties of tenofovir in human liver cells;Health Sciences Review;2023-09

5. Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population;CPT: Pharmacometrics & Systems Pharmacology;2023-04-04